Page last updated: 2024-10-23

baclofen and Lesch-Nyhan Syndrome

baclofen has been researched along with Lesch-Nyhan Syndrome in 2 studies

Lesch-Nyhan Syndrome: An inherited disorder transmitted as a sex-linked trait and caused by a deficiency of an enzyme of purine metabolism; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE. Affected individuals are normal in the first year of life and then develop psychomotor retardation, extrapyramidal movement disorders, progressive spasticity, and seizures. Self-destructive behaviors such as biting of fingers and lips are seen frequently. Intellectual impairment may also occur but is typically not severe. Elevation of uric acid in the serum leads to the development of renal calculi and gouty arthritis. (Menkes, Textbook of Child Neurology, 5th ed, pp127)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pozzi, M1
Piccinini, L1
Gallo, M1
Motta, F1
Radice, S1
Clementi, E1
Gedye, A1

Other Studies

2 other studies available for baclofen and Lesch-Nyhan Syndrome

ArticleYear
Treatment of motor and behavioural symptoms in three Lesch-Nyhan patients with intrathecal baclofen.
    Orphanet journal of rare diseases, 2014, Dec-12, Volume: 9

    Topics: Adult; Baclofen; Behavioral Symptoms; Humans; Lesch-Nyhan Syndrome; Male; Motor Skills Disorders; Se

2014
Serotonin-GABA treatment is hypothesized for self-injury in Lesch-Nyhan syndrome.
    Medical hypotheses, 1992, Volume: 38, Issue:4

    Topics: Baclofen; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans; Kynurenine; Lesch-Nyhan Syndro

1992